Annexin-A5(Immunomodulation) | m-entrepreneurship.com

Product Name :
Annexin-A5(Immunomodulation)

Search keywords :
JMJD6

drugId :
null

Target Vo:
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6

Target Vo Short Name :
JMJD6

Moa_Name:
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Stanford University

Active Company_Name :
Stanford University

Active Indication_Name:
Hemorrhagic Fever, Ebola

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RhoA Antibody
V5-tag Antibody
RSK1 p90 Antibody (YA088): RSK1 p90 Antibody (YA088) is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK1 p90. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts